IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Jounce Therapeutics Inc (JNCEEUR)

CUSIP: 481116101 | XS | 321 institutional holders

Quarters

Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2023

Opaleye Management Inc.669,944
0.2% of portfolio›$917.8K
StyleTurnoverLocationFiled
Opaleye Management Inc.
669,944$917.8K0.2%Agg GrowthMediumBoston, MA2023-08-14